Spice ruins lives and costs taxpayers a fortune. It doesn’t have to be this way | David Nutt

Last year I wrote to the health and home secretaries with suggestions on how antidotes for spice could be developed. Their replies revealed a complete lack of appreciation of the magnitude of the synthetic cannabinoid problem and lack of interest in the idea of an antidote.

Spice-induced “zombie” outbreaks in New York and in Manchester have hit the headlines in the past year. Use of these new damaging and powerful forms of synthetic cannabinoids is rife in our prisons and by homeless people, with estimates of up to 50 deaths last year. They can produce extremely strong psychotic states often with very violent behaviour. Sometimes a frozen unconscious state results. Either of these outcomes are health emergencies that consume vast amounts of police, prison officer and health professionals time, and so waste a huge amount of public money.

Spice is a generic term for the hundreds of synthetic versions of cannabis that are used instead of herbal cannabis. The first synthetic cannabinoids were made in the 1970s as potential medicines, but initial human testing found them to be so unpleasant and potent in their actions that none were marketed. Since then they have been sold as legal alternatives to cannabis, and called spice.

The problems with spice are multiple. The first is lack of any quality control: the amount of synthetic cannabinoid in each unit is not known. Second, these substances have little, if any, safety data. Third, many of them are much more potent than traditional cannabis, up to a hundred times more potent in the test tube and have never been tested in animals – let alone humans – so there is no data on real-world safety.

Most are not detectable by current testing processes which is why prisoners prefer them. This high potency means they are very profitable drugs. A spice solution costing a few pounds can be soaked into a single A4 sheet of paper, which, when dried, can be cut up into about 100 units, each of which will give a decent “hit” at £5 each.

The government’s response has been to ban these drugs in a series of amendments to the misuse of drugs act. So now all synthetic cannabinoids are illegal. But, as with other drugs, banning spice doesn’t stop its use. Heroin has been illegal for 50 years yet deaths reached an all-time peak in England and Wales last year.

So what should the government do about spice? First, it must recognise that this problem is not going to be dealt with by simplistic approaches such as more bans or more severe sentencing of users. We should understand that the authorities’ focus on herbal cannabis use is the main reason for spice emerging in the UK. So we should stop testing for cannabis in prisoners and others to encourage a move by users back to herbal cannabis.

The Manchester police commissioner has now publicly wondered if the problem has been exacerbated by the Psychoactive Substances Act which has taken synthetic cannabinoids out of “head shops” and into the underground marketplace. Perhaps we should develop a harm reduction strategy by allowing the sale of safer versions of synthetic cannabinoids, or even cannabis itself, back in head shops?

But to deal with the current epidemic of use we need urgently to develop cannabis antagonists as antidotes to spice for use by health professionals.

The success of naloxone as an antidote for heroin overdose is now well recognised to save lives, and is given to opioid users and their friends for this reason. Several antagonists at the cannabis receptor are known and one, rimonabant, has extensive safety data in humans. It was licensed in Europe a decade ago as a treatment to stop weight gain after people stopped smoking. However post-marketing surveillance found that in some people rimonabant was associated with an increase in depressive reactions, sometimes with suicidal thinking (though not suicides). This led to it being taken off the market for having too low a benefit-risk ratio for this medical indication. But for spice reversal these considerations do not apply – it would only be used once to reverse a bad reaction, and hopefully keep people from harming themselves or others.

The other approach is to develop the herbal antidote THCV. This is made in the cannabis plant alongside d9THC and many other cannabinoids. It has recently been shown to have antagonist actions against the psychosis produced by d9THC and so would almost certainly attenuate spice intoxication. Sadly, just a few months ago, the Advisory Council for the Misuse of Drugs refused to make it available for this purpose on the spurious grounds that a note in a 1974 paper said that when given intravenously in high doses it was a little like d9THC.

Surely it is time for government to push to develop such an antidote to spice if not for humane and health reasons then for economic ones?

Spice ruins lives and costs taxpayers a fortune. It doesn’t have to be this way | David Nutt

Arkansas" "Private Option" Value Tag Is Growing By The Month Below Obamacare"s Medicaid Expansion, State Taxpayers To Pay out Tens Of Millions

This publish is co-authored with Jonathan Ingram.

Any Governor or legislator still contemplating a “Private Option” design ObamaCare Medicaid growth in their state ought to consider an additional-extended look, as the Razorback state’s edition is turning out to be hugely costly. Even though the “Private Option” programs are essential to look nearly exactly the exact same as Previous Medicaid from an enrollee’s viewpoint, the prepare does have one massive big difference from a straight “traditional” ObamaCare Medicaid expansion: state taxpayers are on the hook for all expense overruns. The trend of enrollment in the 1st couple of months venture a price overrun of tens of millions of dollars for 2014 alone, with likely overruns growing larger in the future.

We just lately talked to Arkansas state Representative Joe Farrer (R-44), who has been warning his colleagues of these possible problems for fairly some time. When asked what lawmakers both in his very own state and around the country need to know, here’s what he had to say:

These expense overruns have designed tens of hundreds of thousands of new causes why the Private Choice should be repealed. A lot of of us warned that this program was going to be a income pit we are already being established correct and Arkansas taxpayers are going to finish up on the hook.

Except if we reverse program, we are going to have to make large cuts to vital state services—including these that truly vulnerable, elderly and disabled sufferers rely upon—or increase taxes even a lot more in buy to maintain pumping income into this giant broken promise. How many sufferers will have to suffer and how a lot of family members budgets will get a hit ahead of Personal Choice supporters admit this ObamaCare Medicaid expansion scheme has failed?

The New York Instances, Hillary Clinton &amp Some Republicans Have Endorsed The Personal Choice As GOP-safe Medicaid Expansion

Media accounts have manufactured a quite huge deal about the “GOP-conceived alternative” to Medicaid expansion. This has led to speculation that the prepare helps make it politically less difficult for red states to assistance ObamaCare’s Medicaid expansion. The dilemma is that, as we discover a lot more about the fine print of the last deal and view early implementation, the plan looks like a horrible deal for taxpayers in Arkansas and consists of all of the same federal strings that make Old Medicaid such a dysfunctional program in the 1st location.

The further charges will directly crowd-out investing on other public priorities like schooling, public safety and infrastructure investments. But worse than that, as Representative Farrer would like other states to consider, it will hurt the most vulnerable already protected by the pre-ObamaCare security net: mainly poor kids, seniors and men and women with disabilities.

In the odd submit-ObamaCare era of Medicaid growth debates, a strategy roundly endorsed by each The New York Times editorial board and Hillary Clinton has not dampened the interest from some Republican legislators hoping to secure their own version of the Arkansas model. The idea has spread to states like Iowa, New Hampshire, Pennsylvania, and Utah. Yet a lot of fail to recognize how the Arkansas program is structured, and move past the rosy rhetoric of the Personal Choice.

How Arkansas Policymakers Put Their Residents On The Hook

ObamaCare advocates repeatedly guarantee state lawmakers that Medicaid expansion is totally-funded by the federal government, at least through 2016.  Advocates repeated this guarantee for the Arkansas Personal Alternative Medicaid expansion, which sought to use ObamaCare’s Medicaid funding to supply Medicaid advantages to a new class of operating-age, able-bodied adults by means of ObamaCare exchange plans.

But under terms of the Private Choice federal waiver signed by Governor Beebe and the Obama administration, state taxpayers will be on the hook for any value overruns. The unique terms and conditions of the Private Choice waiver attribute month to month per-particular person caps on federal investing for every of the up coming three many years. A widespread characteristic of Medicaid waivers, these caps are meant to shield the federal taxpayer if the Private Option ends up becoming much more costly than previously estimated.

Beneath the terms of the waiver, the state taxpayer is accountable for all charges which exceed these per-enrollee caps. At the end of the waiver period, the federal government will calculate how a lot Arkansas invested on the Private Choice Medicaid expansion and compare it to the yearly price range caps agreed to in the waiver. Any quantities more than individuals caps should then be repaid to the federal government from state tax bucks.

Private Choice Already Exceeding Federal Cap

Just three months into the program, costs have been far over the state’s initial projections. When the Personal Alternative originally passed, consultants for the Arkansas Department of Human Solutions projected that the system would price $ 437 per individual per month in 2014. But the Division of Legislative Audit reports that the Personal Option had an average month-to-month price of $ 476.59 per individual in January alone. By February, the Division of Human Providers reported average regular monthly expenses had enhanced to $ 483.15 per individual. In March, the typical monthly charges grew even higher, reaching $ 485.77.

Despite the fact that the state developed a minor wiggle space into the cap it negotiated with the federal government, the Personal Option started to exceed the month to month per-enrollee cap of $ 477.63 in February, the second total month of the program, with expenses continuing to improve thereafter. The waiver does supply the state an possibility to inquire for an adjustment to this cap, but this would call for added federal approval and is supposed to only be granted for problems in participation costs and related aspects.

Arkansas" "Private Option" Value Tag Is Growing By The Month Below Obamacare"s Medicaid Expansion, State Taxpayers To Pay out Tens Of Millions